Shares of Walgreen Boots Alliance and Rite Aid are trading lower after the merger of the two drugstore companies is facing US antitrust concerns. » Read More
By: Mike Juang
The lung cancer treatment is still expected to receive approval in the second half of 2018. » Read More
Costco Wholesale will pay $11.75 million to resolve claims that some of its pharmacies filled improper or incomplete prescriptions for controlled substances » Read More
Walgreens settles U.S. lawsuit that accuses company of incentivizing the fulfillment of government healthcare prescriptions. » Read More
CNBC's David Faber reports the latest on Abbott Laboratories going to court in Delaware to end its proposed acquisition of Alere.
Britain's competition watchdog has fined Pfizer a record 84.2 million pounds ($107 million) for its role in ramping up the cost of an epilepsy drug by as much as 2,600 percent.
Jeff Jonas, Sage Therapeutics CEO, discusses his company's new drug to treat postpartum depression and the current drug pricing environment.
The drug is for the treatment of moderate to severe menapause symptoms like hot flashes and night sweats.
TJ Parker, PillPack co-founder & CEO, talks about his company's plans to disrupt the pharmacy businesses.
CNBC's Martin Soong reports on the growth potential of the pharmaceutical industry in India, the largest generic drug producer in the world.
CEO David Schenkein explained that concerns for the molecule were specific to an "extremely high dose, a dose that we would never use in patients."
Incyte president & CEO Herve Hoppenot speaks to CNBC's Meg Tirrell about the growth of bone marrow drug Jakafi, drug pricing under Donald Trump and the company's drug pipeline.
CNBC's Meg Tirrell speaks with Celgene CEO Mark Alles at the American Society of Hematology about the company's immunotherapy partnerships and the upcoming Trump administration.
Looking to improve your overall well-being? These apps can help you keep tabs on your health while reducing stress.
The agency said Friday that it approved a new indication for a drug marketed by Eli Lilly and Boehringer Ingelheim.
Kenneth Frazier, the CEO of pharmaceutical giant Merck, says Trump's call to revamp Obamacare could prove useful.
Researchers have found a functional link between gut bacteria and Parkinson's disease.
CNBC's Meg Tirrell speaks with Express Scripts chief medical officer Dr. Steve Miller about the role of pharmacy benefits managers in drug pricing.
CNBC's Meg Tirrell speaks with Bluebird Bio CEO Nick Leschly about his company's successful study of its multiple myeloma treatment as well as the election effect on the biotech sector.
Three Vancouver companies told CBC Toronto there is a lot of demand from people looking to move away from traditional medicines to cannabis.
Get the best of CNBC in your inbox